These results indicate that 7,8-DHF treatment suppresses the accumulation of α-synuclein, and reduces oxidative stress through the induction of TrkB activation and subsequently blocks the loss of DAergic neurons in the SN and striatum of PD patients. Here, SNCA is linked to Parkinson disease.